The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNIC.L Regulatory News (CNIC)

  • There is currently no data for CNIC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Awards and Exercise of Options

17 Apr 2023 07:00

RNS Number : 3219W
CentralNic Group PLC
17 April 2023
 

17 April 2023

CentralNic Group plc

 

("CentralNic" or the "Company")

 

(AIM: CNIC)

 

Share Awards and Exercise of Options

 

Share Awards

 

CentralNic announces that on 14th April 2023 it has made awards over ordinary shares of £0.001 each ("Ordinary Shares") under the CentralNic Group plc Long Term Incentive Plan and the CentralNic Group plc Share Option Plan (the "LTIP" and "SOP") to Group employees of CentralNic ("Awards"). 

The Awards were granted as nil-cost options under the terms of the LTIP and/or the SOP (as relevant) over a total of 1,504,619 Ordinary Shares. The Awards under the LTIP and SOP vest over a three-year period subject to the continued employment of the Award holder.

 

Exercise of Options

 

CentralNic further announces that on 14 April 2023 Michael Riedl, CEO, has exercised the following share options previously granted by the Company ("Options):

 

PDMR

Number of Ordinary Shares acquired on exercise of Options

Date of grant of Option

Michael Riedl

53,250

10 March 2020

Michael Riedl

231,050

10 March 2020

Michael Riedl

231,050

10 March 2020

Michael Riedl

173,288

10 March 2020

 

The exercise of options was satisfied by 688,638 shares from the CentralNic Employee Benefit Trust. Michael Riedl intends to keep all the shares acquired through the exercise of his options and has no plans to sell any shares in the foreseeable future.

 

Following the exercise of his options, Michael Riedl holds 2,726,776 Ordinary Shares, representing 0.95% of the total voting rights of the Company.

 

The table below summarises the total number of Ordinary Shares under options held by the Directors as at the date of this announcement:

 

Director

Number of Ordinary Share subject to options

Issue Date

Vesting date

Exercise price per Ordinary Share

Michael Riedl

231,050

10 March 2020

1 March 2022 - 1 March 2024

Nil

Michael Riedl

462,100

10 March 2020

1 March 2023 - 1 March 2025

Nil

William Green

18,181

7 March 2022

1 Jan 2023 - 1 Jan 2025

Nil

 

A total number of 9,801,242 Ordinary Shares are held under options granted to all employees and Directors of the CentralNic group.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Michael Riedl

2

Reason for the notification

a)

Position/status

CEO

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CentralNic Group plc

b)

LEI

213800M4IINBWMXEKV82

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.001

 

GB00BCCW4X83

b)

Nature of the transaction

Exercise of share options & Sale

c)

Price(s) and volume(s)

Exercise of share option

 Price(s)

Volume(s)

0p

0p

0p

0p

53,250

231,050

231,050

173,288

 

 

 

d)

Aggregated information

- Aggregated volume

- Price

Transaction Type

Aggregated Volume

Aggregated Price

Exercise of Options

 688,638

0p

e)

Date of the transaction

14 April 2023

f)

Place of the transaction

Outside of trading venue

 

 

 

For further information contact:

 

CentralNic Group Plc

Michael Riedl, Chief Executive Officer

William Green, Chief Financial Officer

 

+44 203 388 0600

Zeus Capital Limited (NOMAD Joint Broker)

Nick Cowles / Jamie Peel / James Edis (investment Banking)

Dominic King (Corporate Broking)

 

+44 161 831 1512

+44 203 829 5000

Berenberg (Joint Broker)

Mark Whitmore / Richard Andrews / Alix

Mecklenburg-Solodkoff 

 

+44 (0) 20 3207 7800

SEC Newgate (for Media)

Bob Huxford / Alice Cho / Harry Handyside

+44 (0) 203 757 6880

centralnic@secnewgate.co.uk

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUGDSUSBDGXS
Date   Source Headline
15th Dec 202211:23 amRNSDirectors' Dealings
12th Dec 20227:00 amRNSLEADERSHIP CHANGE, UPDATE, SHARE BUYBACK INTENTION
30th Nov 20229:58 amRNSDirectors’ Dealings
28th Nov 20227:00 amRNSDirectors’ Dealings
28th Nov 20227:00 amRNSHolding(s) in Company
22nd Nov 20227:00 amRNSNINE MONTHS ENDED 30 SEP 2022 FINANCIAL RESULTS
9th Nov 20227:00 amRNSNotice of Results
31st Oct 202211:00 amRNSSuccessful Completion of Refinancing
26th Oct 20227:00 amRNSAcquisition Announcement
24th Oct 20221:32 pmRNSDirectors' Dealings
17th Oct 20227:00 amRNSQ3 Traing Upate, Refinancing Notice of Results
17th Oct 20227:00 amRNSQ3 Trading Update, Refinancing & Notice of Results
12th Oct 20221:59 pmRNSDirectors’ Dealings
12th Oct 202210:36 amRNSHolding(s) in Company - Replacement
11th Oct 20224:01 pmRNSHolding(s) in Company
11th Oct 20223:59 pmRNSHolding(s) in Company
7th Oct 20227:00 amRNSDirectors' Dealings
5th Oct 20227:00 amRNSDirectors’ Dealings
29th Sep 20227:00 amRNSDirectors’ Dealings
26th Sep 20227:00 amRNSDirectors' Dealings
14th Sep 20227:01 amRNSBoard Changes
14th Sep 20227:00 amRNSAcquisition Announcement
6th Sep 20225:38 pmRNSDirectors' Dealings
30th Aug 20227:00 amRNSSIX MONTHS ENDED 30 JUNE 2022 FINANCIAL RESULTS
29th Jul 20225:07 pmRNSDirectors' Dealings
25th Jul 20227:00 amRNSExercise of Options
18th Jul 20227:02 amRNSKeyDrive SA Final Add. Consideration Determined
18th Jul 20227:01 amRNSDirectors' Dealings
18th Jul 20227:00 amRNSH1 2022 Trading Update and Notice of Results
23rd May 20227:00 amRNSTHREE MONTHS ENDED 31 MARCH 2022 FINANCIAL RESULTS
4th May 20225:00 pmRNSResult of AGM
25th Apr 20227:00 amRNSQ1 2022 Update, Outlook & Notice of Results
7th Apr 20227:00 amRNSDirector Dealing
4th Apr 20223:49 pmRNSAnnual Report 2021 and Notice of Q1 Update and AGM
29th Mar 202212:22 pmRNSHolding(s) in Company
18th Mar 20221:20 pmRNSResult of Open Offer And Notice of Results
8th Mar 20225:14 pmRNSHolding(s) in Company
8th Mar 20221:52 pmRNSHolding(s) in Company
8th Mar 20227:00 amRNSAcquisition of VGL completed and FT1000 inclusion
7th Mar 20227:00 amRNSShare Awards and Exercise of Options
2nd Mar 20223:58 pmRNSDirectors' Dealings
2nd Mar 20223:54 pmRNSHolding(s) in Company
2nd Mar 202211:13 amRNSHolding(s) in Company
28th Feb 202210:07 amRNSResult of Placing and Launch of Open Offer
28th Feb 20227:01 amRNSProposed Acquisition, Placing and Open Offer
28th Feb 20227:00 amRNSUnaudited Preliminary Results Full Year 2021
14th Feb 20227:00 amRNSTrading Update, Acquisitions, Presentations
3rd Feb 20227:00 amRNSInvestor Presentation
17th Jan 20227:00 amRNSTrading Update and Notice of Results
6th Dec 20217:00 amRNSAcquisition Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.